top of page
PARTNERS
EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D).
OUR PARTNERS
Global network for worldwide impact
Stanford University School of Medicine
USA
Statens Serum Institut (SSI)
Denmark
Steinbeis 2i GmbH
Germany
Stockholm University
Sweden
Sumitomo Pharma Co., Ltd.
Japan
Swiss Tropical Institute
Switzerland
Swiss Tropical and Public Health Institute
Switzerland
Takeda Pharmaceuticals International AG
Switzerland
Technical University of Denmark
Denmark
The Michael Ogon Laboratory for Orthopaedic Research (MOLOR)
Austria
The Regional Hospital Centre of Tirana (RHST)
Albania
Themis Bioscience
Austria
Tuberculosis Vaccine Initiative
The Netherlands
UK Health Security Agency (formerly Public Health England (PHE))
United Kingdom
Universidad de Santiago de Compostela / Center for Research in Molecular Medicine and Chronic Diseases (CiMUS)
Spain
Universidade Nova de Lisboa (NOVA)
Portugal
Universite Pierre et Marie Curie
France
University College Dublin, National University of Ireland
Ireland
University College London
United Kingdom
University Hospital Cologne
Germany
Contact us
We'd love to hear from you!
For the latest updates follow EVI on:
bottom of page